key: cord-0979684-ba09miqm
authors: Mack, Dietrich; Gärtner, Barbara Christine; Rössler, Annika; Kimpel, Janine; Donde, Katrin; Harzer, Oliver; Krutsch, Werner; von Laer, Dorothee; Meyer, Tim
title: Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases
date: 2020-12-05
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.11.033
sha: ee228ce85712e5899ed85a6e847debfc4f720286
doc_id: 979684
cord_uid: ba09miqm

OBJECTIVES: Elite professional football players and staff are a unique group that might give insight into the epidemiology of SARS-CoV-2 infections in Germany and thus can serve as a model for a geographical distribution and an estimation of undetected infections. METHODS: In this prospective cohort study seroprevalence was determined twice in May and June 2020 in players and staff from German Bundesliga. As screening assays a commercial ELISA (Euroimmun) and a CLIA (Roche) was used and an in-house neutralisation assay (NT) as gold standard. Participants were tested twice weekly using PCR from nasopharyngeal and/or oropharyngeal swabs. RESULTS: Seroprevalence (NT used as confirmation) in 2,164 samples from 1,184 players and staff was rather similar in May (23/1157 (1.99%)) and in June (21/1007 (2.09%)). All participants were PCR negative during the study period. Significant regional differences in seroprevalence were not observed. When comparing seroprevalence with the cumulative incidence of infections derived from the German notification system (subgroup matching to cohort; men, age: 20-69), IgG was found 8-10 times more frequently, pointing to a high rate of undetected infections. ELISA and CLIA correlated only moderately (Kappa 0.52). CONCLUSIONS: Seroprevalence with high quality diagnostic in Germany seemed to be around 2%. The number of undetected infections seems to be 8-10 times higher than notification data. Quality of antibody assays is rather variable, thus results should ideally be confirmed at least by a second assay to prove IgG positivity.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic virus causing mainly a 2 respiratory disorder . Prevalence of infection, its local distribution and the number of 3 undetected infections compared to notification data are important figures in epidemiology. One 4 shutdown measure was to suspend the German football. However, the Bundesliga and Bundesliga 2 5 with more than 1,700 players and staff established a special hygiene concept with matches behind 6 closed doors in mid-May [1, 2] . 7

In this study we determined the prevalence of SARS-CoV-2 IgG in more than 1,000 players and staff 8 of the Bundesliga at two time points with two different screening assays and a neutralisation assay 9 (NT) as confirmation. Comparison with notification data enabled to estimate the number of 10 undetected infections. 11

Inclusion criteria: In this 2 months prospective observational study all 36 professional soccer teams 14 (players and staff in direct contact with players (e.g. coaches, physiotherapists)) in Germany were 15 invited. Exclusion criteria were lack of written informed consent. Primary outcome was IgG positivity. 16

All participants were tested twice weekly using nasopharyngeal and/or oropharyngeal swab by PCR 17 starting at least two weeks prior to first serum sampling [2] . 18

Ethical approval was obtained from the Landesärztekammer Rheinland-Pfalz, Germany (Registration 20 1 (EUROimmun, Lübeck, Germany) and the Cobas Elecsys Anti-SARS-CoV-2 CLIA (Roche, Mannheim, 2 Germany) were processed according to the manufacturers' instruction. 3

An NT was employed for confirmation in all samples that tested equivocal or positive in at least one 4 of the two screening assays. In case of paired samples with reactivity in only one of them both 5 samples were retested in NT. Details of the NT were described elsewhere [2] . Interpretation: Samples 6 with titre ≥1:16 were considered positive. 7

Statistical analysis was carried out using GraphPad Prism 8.0 including Cohen's kappa coefficient 9

(agreement between assays) and Chi 2 test (prevalence in geographical regions). Receiver operating 10 characteristic (ROC) curves were calculated by http://www.jrocfit.org. 11

Three out of 36 teams refused to take part since players were already tested earlier. One team 13 provided sera only during the first testing due to logistic reasons. Some individuals took part only 14 once due to personal reasons. Altogether, 812 players (sample pair: 694, single sample: 118) and 372 15 staff members (sample pair: 291, single sample: 81) participated (Supplementary Table S1, Figure S1 ). 16

During the study period (14 days prior to first sampling until last sampling) none had a positive PCR 17 despite twice weekly testing, thus seroconversions were not expected [2].

When comparing the IgG prevalence with the regional notification data (irrespective of age and sex) 22 the number of undetected infections could be estimated to be 9-10 times higher (range 4-21 times; 23

Tab.1) [3]. When using notification data from a subgroup that matches most closely to the cohort 1 (males, age group 20-69) the cumulative incidence according to notification data was 217/100.000 2 and 247/100,000 for calendar week 18 and 24, respectively [5] . This corresponds to a number of 3 undetected infections of factor 8-9 compared to notified infections, respectively. 4

Using ELISA 36/59 positive samples and 5/33 equivocal samples where positive in NT. In CLIA 36/38 5 samples were confirmed. Only 33 samples were congruently positive with both screening assays and 6 all tested positive in NT (Tab 2; Supplementary Table S2, Figure S3 ). 7

In paired sera, the NT showed one reversion (1:16 to negative). In the CLIA results were identical in 8 pairs. In contrast, in ELISA 28 sero-conversions and two reversion occurred (Supplementary Table S3) . 9

Not surprisingly, the screening assays correlated only moderately (Kappa: 0.52 (CI:0.41-0.63)). 10

When using the NT as confirmation these data translate into the test characteristics displayed in 11 Supplementary Table S4 and to the ROC analysis in Supplementary Figure S4 . 12

The prevalence was around 2% in this unique cohort with more than 2,000 samples of elite football 14 players and staff in mid-May and end of June and no confirmed seroconversions (with NT) were 15

found. This is in line with the fact that participants had to adhere to a strict hygiene concept (e.g. 16 home quarantine, distancing and masks whenever possible) during that time and none had a positive 17 differentiation between age and sex) a rate of undetected infections of around factor 9-10 (range 4-1 21) was found. When using the notification data from only men of the age group 20-69 an almost 2 similar factor of 8-9 could be calculated for the entire cohort. It should be kept in mind, that this 3 factor is influenced by the rate of asymptomatic infection but also by the availability of the test 4 capacities, which was problematic in the beginning of the pandemic. Estimations of number of 5 undetected infections were rarely done so far. A study using data from Austria and Iceland found an 6 almost similar factor of 8.35 [9], whereas a factor of 5 was determined in a hot spot area [8] . 7

The correlation between the screening assays was rather low (Kappa 0.52). CLIA results seemed to 8 better correlate with NT and to be more plausible than ELISA since ELISA had a high rate of 9 unexpected seroconversions. Our data suggest that the screening assays must not be used as a 10 standalone diagnostic tool for defining IgG positivity. 11

Limitations of the study are a cohort not matching the German population in all aspects. Women 12 were underrepresented, however, the rate of infection is rather similar between the sexes [5] . 13 Moreover, the age group does not match completely. This is why notification data of a closely 14 matching group were used to determine the rate of undetected infections. 15

The NT was not applied in all sera but only to a selection of mainly positive sera. The rate of false and 16 true negatives might have been different when all sera would have been tested, however rate of true 17 and false positives are not affected by this approach. In addition, we assumed that only persons with 18 detectable neutralising antibodies were true positive, possibly underestimating the performance of 19 the screening assays. 20

In conclusion, prevalence of SARS-CoV-2 IgG in the cohort seemed to be around 2% (May, June 2020) 21 without significant regional differences. Importantly, the number of undetected infections seems to 22 be 8-10 times higher than notification data. Positive IgG results should ideally be confirmed by at 23 least another assay when used as a marker for immunity. 24 J o u r n a l P r e -p r o o f 1 DM, KD, and OH are employees of Bioscientia Labor Ingelheim, which performed antibody testing 2 and received a grant (see funding) for this study. AR, JK and DL did not declare any conflict of 3 interest.TM, WK, BG were members of the DFL task force and received a fee from the DFL for their 4 work in the task force. BG received lecture fees from Roche, and DM from DiaSorin. 5

The study was funded by the DFL (Deutsche Fußball Liga). The DFL had no access to the data and no 7 influence on analysis or the manuscript. 8 Figure S2 ). Dates used for calculation were 14 day prior to 1 st and 2 nd sampling, since IgG production 4 should be expected after this period. Thus, IgG prevalence of 15 th of May corresponds to the 5 cumulative incidence in notification data of 1 st of May. 6 2: Factor of unreported infections was calculated using the cumulative incidence compared to the 7 respective IgG prevalence. 8 9 Table 1 

Sports Medicine / Special Match Operations Task Force in 3

Professional Football 2020

Successful return to 6 professional men´s football (soccer) competition after the COVID-19 shutdown: A

Daily Situation Report of the 9

COVID-19-Dashboard

SARS-CoV-2 IgG seroprevalence in blood donors located in 15 three different federal states

The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% -Screening in 17 asymptomatic outpatients in Germany

Infection fatality 19 rate of SARS-CoV-2 infection in a German community with a super-spreading event

Investigating the dark figure of COVID-19 cases in Austria: 22 Borrowing from the deCODE genetics study in Iceland

Brief clinical evaluation of six high-1 throughput SARS-CoV-2 IgG antibody assays

Comparison of four 3 new commercial serologic assays for determination of SARS-CoV-2 IgG

Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection J 6

Performance Characteristics of Four High-8

Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2

Sex, age, and hospitalization 11 drive antibody responses in a COVID-19 convalescent plasma donor population

 9 We would like to thank all other members of the task force (Markus Braun, Ansgar Schwenken, 10

Results of confirmation Table 2 : Results of the confirmatory neutralisation assay in relation to both screening assays. 5Samples that tested negative in screening assays were included since they belong to serum pairs 6 (see Methods) 7 8 J o u r n a l P r e -p r o o f